Related Experiment Video
Updated: Jun 25, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models
Igor H Sanches1,2,3, Rodolpho C Braga4, Vinicius M Alves5
1Laboratory for Molecular Modeling and Drug Design (LabMol), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO 74690-900, Brazil.
Insights
This study enhances Pred-hERG 5.0, a tool for predicting human Ether-à-go-go-Related Gene (hERG) channel blockage, offering cost-effective, reliable cardiotoxicity assessment. The improved tool provides accurate predictions and visual explanations for drug safety evaluations.
Area of Science:
- Computational chemistry
- Pharmacology
- Drug discovery
Background:
- The human Ether-à-go-go-Related Gene (hERG) channel is crucial for cardiac action potential; its inhibition causes potentially fatal cardiotoxicity.
- Current in vitro methods for identifying hERG blockers are costly, necessitating the development of alternative, cost-effective predictive tools.
Purpose of the Study:
- To enhance the Pred-hERG tool for predicting hERG blockage by developing advanced Quantitative Structure-Activity Relationship (QSAR) models.
- To improve early-stage assessment of drug-induced cardiotoxicity through more accurate and interpretable predictive models.
Main Methods:
- Developed new QSAR models incorporating updated data from ChEMBL v30 (14,364 compounds).
- Updated existing binary and multiclassification models and introduced new regression models for predicting hERG activity (pIC50).
- Integrated SHAP (SHapley Additive exPlanations) values for model interpretability and implemented explainable AI (XAI).
Main Results:
- New binary and multiclassification models demonstrated superior performance compared to previous Pred-hERG versions and other public models.
- The optimal regression model achieved an R² of 0.61 and an RMSE of 0.48, outperforming existing literature models.
- Pred-hERG 5.0 provides classification, multiclassification, regression predictions, probability maps, and SHAP value visualizations.
Conclusions:
- Pred-hERG 5.0 offers a user-friendly, reliable platform for early cardiotoxicity assessment via hERG blockage prediction.
- The tool's enhanced predictive accuracy and explainability support informed decision-making in drug development.
- Accessible to users without computational expertise, Pred-hERG 5.0 is freely available for broader research application.
Abstract:
The human Ether-à-go-go-Related Gene (hERG) is a transmembrane protein that regulates cardiac action potential, and its inhibition can induce a potentially deadly cardiac syndrome. In vitro tests help identify hERG blockers at early stages; however, the high cost motivates searching for alternative, cost-effective methods. The primary goal of this study was to enhance the Pred-hERG tool for predicting hERG blockage. To achieve this, we developed new QSAR models that incorporated additional data, updated existing classificatory and multiclassificatory models, and introduced new regression models. Notably, we integrated SHAP (SHapley Additive exPlanations) values to offer a visual interpretation of these models. Utilizing the latest data from ChEMBL v30, encompassing over 14,364 compounds with hERG data, our binary and multiclassification models outperformed both the previous iteration of Pred-hERG and all publicly available models. Notably, the new version of our tool introduces a regression model for predicting hERG activity (pIC50). The optimal model demonstrated an R2 of 0.61 and an RMSE of 0.48, surpassing the only available regression model in the literature. Pred-hERG 5.0 now offers users a swift, reliable, and user-friendly platform for the early assessment of chemically induced cardiotoxicity through hERG blockage. The tool provides versatile outcomes, including (i) classificatory predictions of hERG blockage with prediction reliability, (ii) multiclassificatory predictions of hERG blockage with reliability, (iii) regression predictions with estimated pIC50 values, and (iv) probability maps illustrating the contribution of chemical fragments for each prediction. Furthermore, we implemented explainable AI analysis (XAI) to visualize SHAP values, providing insights into the contribution of each feature to binary classification predictions. A consensus prediction calculated based on the predictions of the three developed models is also present to assist the user's decision-making process. Pred-hERG 5.0 has been designed to be user-friendly, making it accessible to users without computational or programming expertise. The tool is freely available at http://predherg.labmol.com.br.
More Related Videos
10:39Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Published on: April 15, 2017
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Mechanistic Models: Overview of Compartment Models